Gene · 4320
Papers3,235
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,235
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association between 21-gene-assay and detection of disseminated tumor cells in patients with early breast cancer: results from the IRMA trial. | Breast Cancer Res Treat | 2023 | 37556015 | PubTator, text mining | PubMed |
| New insights into the role of adipocytes in pancreatic cancer progression: paving the way towards novel therapeutic targets. | Theranostics | 2023 | 37554282 | PubTator, text mining | PubMed |
| Invasive Breast Cancer with HER2 ≥4.0 and <6.0: Risk Classification and Molecular Typing by a 21-Gene Expression Assay and MammaPrint Plus BluePrint Testing. | Breast Cancer (Dove Med Press) | 2023 | 37554155 | PubTator, text mining | PubMed |
| Regulatory role of exosomes in colorectal cancer progression and potential as biomarkers. | Cancer Biol Med | 2023 | 37553810 | PubTator, text mining | PubMed |
| Comprehensive bioinformatics analysis and experimental validation: An anoikis-related gene prognostic model for targeted drug development in head and neck squamous cell carcinoma. | Oncol Res | 2023 | 37547764 | PubTator, text mining | PubMed |
| Identification and comprehensive analysis of epithelial-mesenchymal transition related target genes of miR-222-3p in breast cancer. | Front Oncol | 2023 | 37546414 | PubTator, text mining | PubMed |
| Spatial tumour gene signature discriminates neoplastic from non-neoplastic compartments in colon cancer: unravelling predictive biomarkers for relapse. | J Transl Med | 2023 | 37543577 | PubTator, text mining | PubMed |
| Anoikis resistance--protagonists of breast cancer cells survive and metastasize after ECM detachment. | Cell Commun Signal | 2023 | 37537585 | PubTator, text mining | PubMed |
| Protective effects of red orange (Citrus sinensis [L.] Osbeck [Rutaceae]) extract against UVA-B radiation-induced photoaging in Skh:HR-2 mice. | Nutr Res Pract | 2023 | 37529272 | PubTator, text mining | PubMed |
| Single-cell transcriptome sequencing of B-cell heterogeneity and tertiary lymphoid structure predicts breast cancer prognosis and neoadjuvant therapy efficacy. | Clin Transl Med | 2023 | 37525587 | PubTator, text mining | PubMed |
| circRNA-SFMBT2 orchestrates ERα activation to drive tamoxifen resistance in breast cancer cells. | Cell Death Dis | 2023 | 37524698 | PubTator, text mining | PubMed |
| Assessment of tumor microenvironment in gastric adenocarcinoma. | Rom J Morphol Embryol | 2023 | 37518883 | PubTator, text mining | PubMed |
| Anti-Inflammatory Effects of Dietary Polyphenols through Inhibitory Activity against Metalloproteinases. | Molecules | 2023 | 37513300 | PubTator, text mining | PubMed |
| Matrix Metalloproteinases and Heart Transplantation-A Pathophysiological and Clinical View. | Medicina (Kaunas) | 2023 | 37512106 | PubTator, text mining | PubMed |
| Expression of Immune-Related and Inflammatory Markers and Their Prognostic Impact in Colorectal Cancer Patients. | Int J Mol Sci | 2023 | 37511338 | PubTator, text mining | PubMed |
| Gender Differences and miRNAs Expression in Cancer: Implications on Prognosis and Susceptibility. | Int J Mol Sci | 2023 | 37511303 | PubTator, text mining | PubMed |
| Extracellular Matrix- and Integrin Adhesion Complexes-Related Genes in the Prognosis of Prostate Cancer Patients' Progression-Free Survival. | Biomedicines | 2023 | 37509645 | PubTator, text mining | PubMed |
| An Update on S100A16 in Human Cancer. | Biomolecules | 2023 | 37509106 | PubTator, text mining | PubMed |
| SARS-CoV-2 NSP1 induces mRNA cleavages on the ribosome. | Nucleic Acids Res | 2023 | 37503833 | PubTator, text mining | PubMed |
| Current Non-surgical Management of Knee Osteoarthritis. | Cureus | 2023 | 37503484 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4320/papers?page=14